middle.news
BIF backs a home-use eye drop aimed at slowing keratoconus
3:29pm on Tuesday 22nd of September, 2026 AEST
•
Healthcare
Read Story
BIF backs a home-use eye drop aimed at slowing keratoconus
3:29pm on Tuesday 22nd of September, 2026 AEST
Key Points
$200,000 investment in seed-stage company TheiaNova
Eye drop designed to regenerate corneal collagen
TheiaNova represents 0.76% of BIF’s portfolio
BIF has a $26.4 million net asset value
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Booster Innovation Fund (NZX:BIF)
OPEN ARTICLE